The Latest Clinical Articles in Oncology & Cancer

1Magnetic resonance imaging–transectal ultrasound image-fusion biopsies accurately characterize the index tumor: Correlation with step-sectioned radical prostatectomy specimens in 135 patientsEuropean Urology, April 01, 2015  Full Text  Clinical Article
2Prevention of bone metastases in patients with high-risk nonmetastatic prostate cancer treated with zoledronic acid: Efficacy and safety results of the Zometa European study (ZEUS)European Urology, April 01, 2015  Full Text  Clinical Article
3Enzalutamide: Targeting the androgen signalling pathway in metastatic castration-resistant prostate cancerBJU International, April 01, 2015  Clinical Article
4Symptoms, unmet needs, psychological well-being and health status in prostate cancer survivors: Implications for redesigning follow-upBJU International, April 01, 2015  Clinical Article
5A Canadian national expert consensus on neoadjuvant therapy for breast cancer: linking practice to evidence and beyondCurrent Oncology, April 01, 2015  Full Text  Review Article
6High pre-operative levels of serum glypican-3 containing N-terminal subunit are associated with poor prognosis in patients with hepatocellular carcinoma after partial hepatectomyInternational Journal of Cancer, April 01, 2015  Review Article
7Osteopontin is a useful predictor of bone metastasis and survival in patients with locally advanced nasopharyngeal carcinomaInternational Journal of Cancer, April 01, 2015  Clinical Article
8Pseudomonas aeruginosa preparation plus chemotherapy for advanced non-small-cell lung cancer: a randomized, multicenter, double-blind phase III studyMedical Oncology, April 01, 2015  Clinical Article
9Expression of mucin 1 possessing a 3 prime-sulfated core1 in recurrent and metastatic breast cancerInternational Journal of Cancer, April 01, 2015
10Outcome of patients with pregnancy during or after breast cancer: a review of the recent literatureCurrent Oncology, April 01, 2015  Full Text  Review Article
1UCLA study reveals treatment for women with breast cancer suffering cognitive difficultiesUCLA Health System, April 01, 2015
2UCLA researchers develop more accurate tool to predict whether liver cancer will recur in transplant patientsUCLA Health System, April 01, 2015
3Eat your veggies to lower colon cancer riskBaylor Health Care System, April 01, 2015
4A possible novel therapy for a rare but potentially fatal blood disorderUAB Medicine, April 01, 2015
5Cancer care in America: A shifting landscapeAmerican Society of Clinical Oncology (ASCO) News, April 01, 2015
6ASCP, CAP, AMP, and ASCO issue draft colorectal cancer molecular marker testing guideline and announce opening of public comment periodAmerican Society of Clinical Oncology (ASCO) News, April 01, 2015
7Study pinpoints pregnancy complications in women with sickle cell diseaseAmerican Society of Hematology News, April 01, 2015
8When cancer cells stop acting like cancerGeorgetown University Medical Center News, April 01, 2015
9ASU researchers search for telltale signs of ovarian cancerArizona State University's News, April 01, 2015
10UCLA researchers develop new combination therapy to fight melanomaUCLA Health System, April 01, 2015

Show Me:

Cisplatin monotherapy effective in pediatric high-risk hepatoblastoma

As reported in the Journal of Pediatric Hematology/Oncology, treatment of children with high-risk hepatoblastoma (n=14) with cisplatin monotherapy was as effective as cisplatin + doxorubicin combination therapy, but with less toxicity. The complete resection rate was 78.6%, the event-free survival rate was 81.8%, and the OS rate was 100%.

YKL-40 predicts poor prognosis for bladder cancer

As reported in Urologic Oncology, the gene expression and serum level of YKL-40 are higher in patients with bladder cancer than healthy controls. Serum YKL-40 levels predict poor prognosis in patients with muscle-invasive bladder cancer (HR=1.75).

CHD7 associated with survival in pancreatic ductal adenocarcinoma patients receiving gemcitabine

As reported in Cancer Research, low CHD7 expression is associated with increased RFS and OS in pancreatic ductal adenocarcinoma patients receiving gemcitabine. There was no association between CHD7 expression and RFS or OS in patients who were not treated with gemcitabine.

Are YOU the Smartest Doc in America?

The Smartest Doc from MDLinx keeps you current with a competitive edge, pitting colleagues against one other for the title of The Smartest Doc in America.

Take the Challenge

Clinical Pearls

Clinical Pearl from Smartest DocRegular aspirin use lowers risk of colorectal cancer in individuals with the T allele of rs6983267.

Clinical Pearl from Smartest DocExposure to indoor tanning before age 23 years greatly increases the risk of basal cell carcinoma.

Clinical Pearl from Smartest DocThiopurines are chemopreventive against colorectal cancer in patients with IBD.

Be Ready for Upcoming 2015 Board Exams!

Be prepared for board reviews with confidence with 1000s of board exam style questions. Prepare Here